SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-011478
Filing Date
2021-08-12
Accepted
2021-08-12 16:09:16
Documents
58
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20210630x10q.htm   iXBRL 10-Q 1658185
2 EX-3.1 elev-20210630xex3d1.htm EX-3.1 45343
3 EX-3.2 elev-20210630xex3d2.htm EX-3.2 232685
4 EX-31.1 elev-20210630xex31d1.htm EX-31.1 11797
5 EX-31.2 elev-20210630xex31d2.htm EX-31.2 11608
6 EX-32 elev-20210630xex32.htm EX-32 7468
  Complete submission text file 0001558370-21-011478.txt   5587856

Data Files

Seq Description Document Type Size
7 EX-101.SCH elev-20210630.xsd EX-101.SCH 33371
8 EX-101.CAL elev-20210630_cal.xml EX-101.CAL 22903
9 EX-101.DEF elev-20210630_def.xml EX-101.DEF 140496
10 EX-101.LAB elev-20210630_lab.xml EX-101.LAB 331584
11 EX-101.PRE elev-20210630_pre.xml EX-101.PRE 260744
12 EXTRACTED XBRL INSTANCE DOCUMENT elev-20210630x10q_htm.xml XML 712732
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 211167596
SIC: 2836 Biological Products, (No Diagnostic Substances)